278
Views
28
CrossRef citations to date
0
Altmetric
Original

Behavioral Counseling Content for Optimizing the Use of Buprenorphine for Treatment of Opioid Dependence in Community-Based Settings: A Review of the Empirical Evidence

, Ph.D., , M.D., M.A. & , M.D.
Pages 643-654 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Min Zhao & Walter Ling. (2012) HIV/AIDS and Drug Use in China—Interactions, Impacts, and Issues. Substance Use & Misuse 47:8-9, pages 1015-1025.
Read now
Walter Ling, Larissa Mooney, Min Zhao, Suzanne Nielsen, Matthew Torrington & Karen Miotto. (2011) Selective review and commentary on emerging pharmacotherapies for opioid addiction. Substance Abuse and Rehabilitation 2, pages 181-188.
Read now
Maureen Hillhouse, Catherine P. Canamar, Geetha Doraimani, Christie Thomas, Albert Hasson & Walter Ling. (2011) Participant Characteristics and Buprenorphine Dose. The American Journal of Drug and Alcohol Abuse 37:5, pages 453-459.
Read now
Maureen Hillhouse, CatherineP. Domier, David Chim & Walter Ling. (2010) Provision of Ancillary Medications During Buprenorphine Detoxification Does Not Improve Treatment Outcomes. Journal of Addictive Diseases 29:1, pages 23-29.
Read now
Ryan K. Schwarz, R. Douglas Bruce, Samuel A. Ball, Maua Herme & Frederick L. Altice. (2009) Comparison of Tuberculin Skin Testing Reactivity in Opioid-Dependent Patients Seeking Treatment with Methadone versus Buprenorphine: Policy Implications for Tuberculosis Screening. The American Journal of Drug and Alcohol Abuse 35:6, pages 439-444.
Read now
WynneE. Norton, K. Rivet Amico, WilliamA. Fisher, MichaelM. Copenhaver, MichaelJ. Kozal, DeborahH. Cornman, Gerald Friedland & JeffreyD. Fisher. (2008) Attitudes toward needle-sharing and HIV transmission risk behavior among HIV+ injection drug users in clinical care. AIDS Care 20:4, pages 462-469.
Read now

Articles from other publishers (22)

Matt Baucum, Anahita Khojandi, Carole Myers & Larry Kessler. (2023) Optimizing Substance Use Treatment Selection Using Reinforcement Learning. ACM Transactions on Management Information Systems 14:2, pages 1-30.
Crossref
Anthony H. Ecker, Julianna B. Hogan, Darius Dawson & Michael A. Cucciare. 2022. Behavior Therapy. Behavior Therapy 563 582 .
Zachary S. Harmon, Emily N. Welch & Christina L. Ruby. 2021. Addictions - Diagnosis and Treatment. Addictions - Diagnosis and Treatment.
Kevin S. Doyle. (2021) The Opioid Crisis: How Counselors Can and Should Respond. Journal of Mental Health Counseling 43:2, pages 112-124.
Crossref
Heather B. Ward, Matthew J. Mosquera, Joji Suzuki & Timothy Y. Mariano. (2020) A Systematic Review of Noninvasive Brain Stimulation for Opioid Use Disorder. Neuromodulation: Technology at the Neural Interface 23:3, pages 301-311.
Crossref
Kathleen M. CarrollRoger D. Weiss. (2019) The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review. FOCUS 17:2, pages 183-192.
Crossref
Micheal L Shier, John R Graham & Jennifer M Keogh. (2019) Social Work and the Emerging Opioid Epidemic: A Literature Review. The British Journal of Social Work.
Crossref
Brandon G. Bergman, Nilofar Fallah-Sohy, Lauren A. Hoffman & John F. Kelly. 2019. Treating Opioid Addiction. Treating Opioid Addiction 109 138 .
Kamilla L. Venner, Dennis M. Donovan, Aimee N.C. Campbell, Dennis C. Wendt, Traci Rieckmann, Sandra M. Radin, Sandra L. Momper & Carmen L. Rosa. (2018) Future directions for medication assisted treatment for opioid use disorder with American Indian/Alaska Natives. Addictive Behaviors 86, pages 111-117.
Crossref
Beth WieseAdrianne R. Wilson-Poe. (2018) Emerging Evidence for Cannabis' Role in Opioid Use Disorder. Cannabis and Cannabinoid Research 3:1, pages 179-189.
Crossref
Adrianne R Wilson‐Poe & Jose A Morón. (2017) The dynamic interaction between pain and opioid misuse. British Journal of Pharmacology 175:14, pages 2770-2777.
Crossref
Suzette Glasner-Edwards, Kevin Patrick, Michele L Ybarra, Cathy J Reback, Richard A Rawson, Helene Chokron Garneau, Kathryn Chavez & Alexandra Venegas. (2016) A Cognitive Behavioral Therapy–Based Text Messaging Intervention Versus Medical Management for HIV-Infected Substance Users: Study Protocol for a Pilot Randomized Trial. JMIR Research Protocols 5:2, pages e131.
Crossref
Joseph El-Khoury, Zeinab Abbas, Pascale E. Nakhle & Marie-Therese Matar. (2016) Implementing opioid substitution in Lebanon: Inception and challenges. International Journal of Drug Policy 31, pages 178-183.
Crossref
Angela Di Paola, Thomas Lincoln, Daniel J. Skiest, Maureen Desabrais, Frederick L. Altice & Sandra A. Springer. (2014) Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community. Contemporary Clinical Trials 39:2, pages 256-268.
Crossref
Britton A. Gibson, Debarchana Ghosh, Jamie P. Morano & Frederick L. Altice. (2014) Accessibility and utilization patterns of a mobile medical clinic among vulnerable populations. Health & Place 28, pages 153-166.
Crossref
Marwan S. Haddad, Alexei Zelenev & Frederick L. Altice. (2013) Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes. Drug and Alcohol Dependence 131:1-2, pages 127-135.
Crossref
Amy Yang, Cynthia L. Arfken & Chris‐Ellyn Johanson. (2013) Steps Physicians Report Taking to Reduce Diversion of Buprenorphine. The American Journal on Addictions 22:3, pages 184-187.
Crossref
Ryan Schwarz, Alexei Zelenev, R. Douglas Bruce & Frederick L. Altice. (2012) Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. Journal of Substance Abuse Treatment 43:4, pages 451-457.
Crossref
Sandra A. Springer, Jingjun Qiu, Ali Shabahang Saber-Tehrani & Frederick L. Altice. (2012) Retention on Buprenorphine Is Associated with High Levels of Maximal Viral Suppression among HIV-Infected Opioid Dependent Released Prisoners. PLoS ONE 7:5, pages e38335.
Crossref
Ali Shabahang Saber-Tehrani, Sandra A. Springer, Jingjun Qiu, Maua Herme, Jeffrey Wickersham & Frederick L. Altice. (2012) Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community — A potential conduit to improved HIV treatment outcomes. Contemporary Clinical Trials 33:2, pages 436-444.
Crossref
Sandra Ann Springer, Shu Chen & Frederick L. Altice. (2010) Improved HIV and Substance Abuse Treatment Outcomes for Released HIV-Infected Prisoners: The Impact of Buprenorphine Treatment. Journal of Urban Health 87:4, pages 592-602.
Crossref
Carlo C. DiClemente, Meredith A. Holmgren & Daniel Rounsaville. 2011. Addiction Medicine. Addiction Medicine 765 782 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.